MedcoHealth Solutions Inc. (NYSE: MHS) is a company we have somewhat expected might succumb to consolidation in the arena surrounding healthcare. Express Scripts Inc. (NASDAQ: ESRX) is offering some $29 billion to acquire Medco…
Nabi Biopharmaceuticals (NASDAQ: NABI) actually finds itself in a strange situation after Monday’s awful news that its NicVAX nicotine conjugate immunotherapeutic failed to meet its primary endpoint in the first of two confirmatory Phase…
Implanted medical devices are one of the most profitable businesses of the U.S. healthcare industry. While many devices help extend and improve quality of life, a great many others may not be necessary. In…
The federal and state governments spend approximately $5,296 a year on medical treatment for each poor and disabled person on Medicaid. Over 58 million Americans are enrolled in Medicaid. These average payments per patient…
Despite being one of the wealthiest countries in the world, the United States ranks 37th in life expectancy, according to the World Health Organization’s most recent longevity report. While the reasons for this are…
If you have seen the graphic images that will go on cigarette packages late in 2011, you might think that the tobacco companies have finally met their match. The graphic images are intended to…
Many drug companies face a what is called a patent cliff ahead, where the Big Pharma players will have key drugs go off-patent and there will be new generic competition. While this is a…
It is a tale you have heard before… driving down prices or capping hikes by bidding contract renewals out in what feels like a Dutch auction. Today’s daily hat trick comes in a fight between…
Cell Therapeutics, Inc. (NASDAQ: CTICD) has long been a controversial stock. It has brought many rewards for investors and it has also brought much pain to investors. We recently featured its positive development in…
Cell Therapeutics, Inc. (NASDAQ: CTICD) has been very active since its recent 1-for-6 reverse stock split took place on May 16, 2011. Its share volume has increased on all but one of the last…
Boston Scientific Corporation (NYSE: BSX) is already losing its replacement CEO. Ray Elliott has announced that he will retire as President and Chief Executive Officer on December 31, 2011. As this is a by-year-end announcement,…
Neostem, Inc. (AMEX: NBS) is a bit soft this morning after making two separate share sale filings with the SEC. The company has filed to sell shares for existing holders and it has filed…
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) has trumped Valeant Pharmaceuticals International, Inc. (NYSE: VRX) after it agreed to acquire Cephalon Inc. (NASDAQ: CEPH) in a $6.8 billion deal. The merger will give the mostly-generic Teva a portfolio…
Tenet Healthcare Corporation (NYSE: THC) has good news and bad news this morning. Community Health Systems, Inc. (NYSE: CYH) has done what many expected by raising its buyout offer for Tenet. The company raised…
Jon OggThis last week marked another solid week for investors and many stocks were on the move. We have compiled a list of stocks we are looking for event-driven trading moves in the coming…